Mednax Inc. Hits New 52-Week High at $103.07 (MD)
Shares of Mednax (NYSE:MD) hit a new 52-week high during trading on Thursday, Analyst Ratings News reports. The stock traded as high as $103.07 and last traded at $103.06, with a volume of 196,177 shares trading hands. The stock had previously closed at $100.85.
Several analysts have recently commented on the stock. Analysts at Deutsche Bank raised their price target on shares of Mednax from $91.00 to $104.00 in a research note to investors on Wednesday. They now have a “hold” rating on the stock. Separately, analysts at Credit Suisse raised their price target on shares of Mednax from $90.00 to $97.00 in a research note to investors on Thursday, August 1st. They now have a “neutral” rating on the stock. Finally, analysts at Piper Jaffray Cos. raised their price target on shares of Mednax from $100.00 to $112.00 in a research note to investors on Wednesday, July 31st. They now have an “overweight” rating on the stock. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $98.00.
Mednax has a 52-week low of $67.86 and a 52-week high of $102.97. The stock has a 50-day moving average of $99.87 and a 200-day moving average of $93.80. The company has a market cap of $5.107 billion and a P/E ratio of 19.71.
Mednax (NYSE:MD) last announced its earnings results on Tuesday, July 30th. The company reported $1.37 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.36 by $0.01. The company had revenue of $529.18 million for the quarter, compared to the consensus estimate of $533.39 million. During the same quarter in the prior year, the company posted $1.22 earnings per share. The company’s quarterly revenue was up 17.7% on a year-over-year basis. Analysts expect that Mednax will post $5.46 EPS for the current fiscal year.
MEDNAX, Inc (NYSE:MD) is a provider of physician services, including newborn, maternal-fetal, pediatric subspecialties and anesthesia care.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.